Supernus Gets Partial Win In Drug Patent Row With Actavis
Supernus Pharmaceuticals Inc. won a partial victory Friday in its bid to stop Actavis Inc. from bringing a generic version of the epilepsy drug Oxtellar XR to market when a New...To view the full article, register now.
Already a subscriber? Click here to view full article